A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.
- Published In:
- Molecules (Basel, Switzerland), 23(11) (2018)
- Authors:
- Swenson, Steve, Minea, Radu O, Tuan, Cao Duc, Thein, Thu-Zan, Chen, Thomas C, Markland, Francis S
- Database ID:
- RPEP-03932
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03932APA
Swenson, Steve; Minea, Radu O; Tuan, Cao Duc; Thein, Thu-Zan; Chen, Thomas C; Markland, Francis S. (2018). A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.. Molecules (Basel, Switzerland), 23(11). https://doi.org/10.3390/molecules23112918
MLA
Swenson, Steve, et al. "A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.." Molecules (Basel, 2018. https://doi.org/10.3390/molecules23112918
RethinkPeptides
RethinkPeptides Research Database. "A Novel Venom-Derived Peptide for Brachytherapy of Glioblast..." RPEP-03932. Retrieved from https://rethinkpeptides.com/research/swenson-2018-a-novel-venomderived-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.